A detailed history of Avion Wealth transactions in Exact Sciences Corp stock. As of the latest transaction made, Avion Wealth holds 16 shares of EXAS stock, worth $906. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 7 128.57%
Holding current value
$906
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$42.43 - $70.83 $381 - $637
9 Added 128.57%
16 $1,000
Q2 2024

Jul 26, 2024

BUY
$41.33 - $74.26 $289 - $519
7 New
7 $0
Q2 2023

Jul 14, 2023

BUY
$62.68 - $95.05 $15,670 - $23,762
250 New
250 $23,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.